Literature DB >> 31401286

Epidermal mammalian target of rapamycin complex 2 controls lipid synthesis and filaggrin processing in epidermal barrier formation.

Xiaolei Ding1, Sebastian Willenborg2, Wilhelm Bloch3, Sara A Wickström4, Prerana Wagle5, Susanne Brodesser5, Axel Roers6, Alexander Jais7, Jens C Brüning8, Michael N Hall9, Markus A Rüegg9, Sabine A Eming10.   

Abstract

BACKGROUND: Perturbation of epidermal barrier formation will profoundly compromise overall skin function, leading to a dry and scaly, ichthyosis-like skin phenotype that is the hallmark of a broad range of skin diseases, including ichthyosis, atopic dermatitis, and a multitude of clinical eczema variants. An overarching molecular mechanism that orchestrates the multitude of factors controlling epidermal barrier formation and homeostasis remains to be elucidated.
OBJECTIVE: Here we highlight a specific role of mammalian target of rapamycin complex 2 (mTORC2) signaling in epidermal barrier formation.
METHODS: Epidermal mTORC2 signaling was specifically disrupted by deleting rapamycin-insensitive companion of target of rapamycin (Rictor), encoding an essential subunit of mTORC2 in mouse epidermis (epidermis-specific homozygous Rictor deletion [RicEKO] mice). Epidermal structure and barrier function were investigated through a combination of gene expression, biochemical, morphological and functional analysis in RicEKO and control mice.
RESULTS: RicEKO newborns displayed an ichthyosis-like phenotype characterized by dysregulated epidermal de novo lipid synthesis, altered lipid lamellae structure, and aberrant filaggrin (FLG) processing. Despite a compensatory transcriptional epidermal repair response, the protective epidermal function was impaired in RicEKO mice, as revealed by increased transepidermal water loss, enhanced corneocyte fragility, decreased dendritic epidermal T cells, and an exaggerated percutaneous immune response. Restoration of Akt-Ser473 phosphorylation in mTORC2-deficient keratinocytes through expression of constitutive Akt rescued FLG processing.
CONCLUSION: Our findings reveal a critical metabolic signaling relay of barrier formation in which epidermal mTORC2 activity controls FLG processing and de novo epidermal lipid synthesis during cornification. Our findings provide novel mechanistic insights into epidermal barrier formation and could open up new therapeutic opportunities to restore defective epidermal barrier conditions.
Copyright © 2019 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidermal barrier; Rictor; epidermal lipid synthesis; filaggrin; ichthyosis; mammalian target of rapamycin complex 2

Mesh:

Substances:

Year:  2019        PMID: 31401286     DOI: 10.1016/j.jaci.2019.07.033

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  12 in total

Review 1.  Revisiting the Roles of Filaggrin in Atopic Dermatitis.

Authors:  Verena Moosbrugger-Martinz; Corinne Leprince; Marie-Claire Méchin; Michel Simon; Stefan Blunder; Robert Gruber; Sandrine Dubrac
Journal:  Int J Mol Sci       Date:  2022-05-10       Impact factor: 6.208

2.  Isolation of macrophages from mouse skin wounds for single-cell RNA sequencing.

Authors:  Sebastian Willenborg; Juliana G Roscito; Alexander Gerbaulet; Axel Roers; Andreas Dahl; Sabine A Eming; Susanne Reinhardt
Journal:  STAR Protoc       Date:  2022-04-19

Review 3.  Perspective: Controlling Epidermal Terminal Differentiation with Transcriptional Bursting and RNA Bodies.

Authors:  Duncan Wotherspoon; Clare Rogerson; Ryan F L O'Shaughnessy
Journal:  J Dev Biol       Date:  2020-12-04

4.  The potential pathways underlying the association of propyl-paraben exposure with aeroallergen sensitization and EASI score using metabolomics analysis.

Authors:  Yujin Lee; Eun Lee; Joo-Youn Cho; Man Yong Han; Dong Keon Yon; Hye Mi Jee; Hey Sung Baek; Seung Won Lee
Journal:  Sci Rep       Date:  2021-02-12       Impact factor: 4.379

5.  Study on the Molecular Basis of Huanglian Jiedu Decoction Against Atopic Dermatitis Integrating Chemistry, Biochemistry, and Metabolomics Strategies.

Authors:  Jing Chen; Saizhen Chen; Jinguang Chen; Bixin Shen; Zhengli Jiang; Yubin Xu
Journal:  Front Pharmacol       Date:  2021-12-14       Impact factor: 5.810

Review 6.  Post-Translational Modifications in Atopic Dermatitis: Current Research and Clinical Relevance.

Authors:  Xin Ma; Yi Ru; Ying Luo; Le Kuai; Qi-Long Chen; Yun Bai; Ye-Qiang Liu; Jia Chen; Yue Luo; Jian-Kun Song; Mi Zhou; Bin Li
Journal:  Front Cell Dev Biol       Date:  2022-07-07

Review 7.  Translational control of stem cell function.

Authors:  James A Saba; Kifayathullah Liakath-Ali; Rachel Green; Fiona M Watt
Journal:  Nat Rev Mol Cell Biol       Date:  2021-07-16       Impact factor: 94.444

Review 8.  Recent advances in atopic dermatitis.

Authors:  Kangmo Ahn; Byung Eui Kim; Jihyun Kim; Donald Ym Leung
Journal:  Curr Opin Immunol       Date:  2020-04-13       Impact factor: 7.486

9.  Topical Application of Galgeunhwanggeumhwangryeon-Tang Recovers Skin-Lipid Barrier and Ameliorates Inflammation via Filaggrin-Thymic Stromal Lymphopoietin-Interleukin 4 Pathway.

Authors:  Sang-Hyun Ahn; Su Shin; Yoonju Do; Yunju Jo; Dongryeol Ryu; Ki-Tae Ha; Kibong Kim
Journal:  Medicina (Kaunas)       Date:  2021-12-20       Impact factor: 2.430

10.  Pathogenic Mechanism of Der p 38 as a Novel Allergen Homologous to RipA and RipB Proteins in Atopic Dermatitis.

Authors:  Hyang Jeon; Geunyeong Kim; Ayesha Kashif; Min Hwa Hong; Ji-Sook Lee; Yujin Hong; Beom Seok Park; Eun Ju Yang; In Sik Kim
Journal:  Front Immunol       Date:  2021-10-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.